- The trend backdrop is active with a 11-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
VICO
STO
Week ended 07 Aug 2026
Weekly Investor Report
Vicore Pharma Holding AB (publ) · Healthcare · Biotechnology
Latest close
11.46 SEK
3.1%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 4.3% above the Trend Line and sits at 29.5% of its 52-week range. The latest completed week returned 3.1%, after a -10.2% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
34
out of 100
Latest Close
11.46 SEK
7 Aug 2026
1W Return
3.1%
latest completed week
4W Return
-10.2%
short-term follow-through
12W Return
-0.2%
quarterly tape
Trend Breadth
69.2%
36 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 42.32% based on similar historical setup states.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.1%
Latest completed week; four-week move -10.2%.
Indicator stack
76/44
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.32%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 4.3% above the Trend Line and sits at 29.5% of its 52-week range. The latest completed week returned 3.1%, after a -10.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5712-week average 0.42
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.57Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -10.2% over four weeks, -0.2% over 12 weeks, and -1.2% over one year. The current trend has remained active for 11 consecutive weeks.
Performance by holding period
Active trend streak11 weeks
Active weeks in one year36
Trend breadth69.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.09Latest activity-pressure read.
Pressure change-91.7%Four-week change in activity pressure.
Leadership-7.77Latest relative-leadership reading.
RS change-213.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-37.2%Distance below the 52-week high.
13-week volatility6.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+9.1%Week of 3 Jul.
Worst week-11.0%Week of 17 Jul.
Latest week+3.1%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains7
Flat weeks0
Modest losses9
Sharp losses4
Recent vol6.1%13-week weekly-return volatility.
Base vol6.4%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew5.8% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank88 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Biotechnology
4-week rank49 / 58
Group average3.5%
Trend breadth39.7%
Trend39.7%active weekly trend signals
MD53.4%positive activity pressure
RS22.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape38/100
Trend, activity pressure, participation, and risk combine to a 38/100 tape read.
Indicator analysis71/100Latest 12-week confirmation: trend 11/12, activity pressure 12/12, relative leadership 5/12.
Activity pressure 0.57; No reversal markers Next-Week ExpectancyNegative 42.32%Next-week expectancy is negative with a 42.32% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Vicore Pharma to Commence Trading in the United States on The Nasdaq Stock Market Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 11.46 SEK | 3.1% | 10.99 SEK | 12.00 SEK | 0.09 | -7.77 | 2.3M | On |
| 31 Jul 2026 | 11.12 SEK | -0.9% | 11.02 SEK | 12.04 SEK | 0.46 | -9.16 | 2.2M | On |
| 24 Jul 2026 | 11.22 SEK | -1.2% | 11.02 SEK | 12.08 SEK | 0.75 | -7.03 | 1.6M | On |
| 17 Jul 2026 | 11.36 SEK | -11.0% | 11.01 SEK | 12.12 SEK | 0.96 | -4.23 | 2.7M | On |
| 10 Jul 2026 | 12.76 SEK | -5.1% | 10.96 SEK | 12.14 SEK | 1.04 | 6.83 | 7.9M | On |
| 3 Jul 2026 | 13.44 SEK | 9.1% | 10.87 SEK | 12.16 SEK | 0.72 | 10.70 | 1.3M | On |
| 26 Jun 2026 | 12.32 SEK | 7.1% | 10.77 SEK | 12.17 SEK | 0.55 | 5.06 | 389.4K | On |
| 19 Jun 2026 | 11.50 SEK | 8.7% | 10.69 SEK | 12.20 SEK | 0.62 | -2.32 | 2.3M | On |
| 12 Jun 2026 | 10.58 SEK | -3.5% | 10.65 SEK | 12.24 SEK | 0.74 | -8.04 | 993.4K | On |
| 5 Jun 2026 | 10.96 SEK | -6.3% | 10.63 SEK | 12.28 SEK | 0.96 | -4.85 | 817.4K | On |
| 29 May 2026 | 11.70 SEK | -1.8% | 10.61 SEK | 12.33 SEK | 0.89 | 0.77 | 3.7M | On |
| 22 May 2026 | 11.92 SEK | 3.8% | 10.59 SEK | 12.37 SEK | 0.30 | 2.63 | 2.9M | Off |
| 15 May 2026 | 11.48 SEK | 6.9% | 10.57 SEK | 12.42 SEK | -0.20 | 2.68 | 3.1M | Off |
| 8 May 2026 | 10.74 SEK | 7.6% | 10.57 SEK | 12.50 SEK | -0.72 | -4.89 | 2.2M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.